Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -3.313% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC(C)C(=O)Nc1sc2c(c1C(N)=O)CCN(Cc1ccccc1)C2.Cl
b Cc1ccc(-c2nnc(C)c(N3CC(C)OC(C)C3)n2)cc1
c O=C(NCC1c2ccccc2CCN1C(=O)CN1C(=O)c2ccccc2C1=O)C1CCCCC1
Answer: b. Cc1ccc(-c2nnc(C)c(N3CC(C)OC(C)C3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-c2nnc(C)c(N3CC(C)OC(C)C3)n2)cc1
Cc1ccc(-c2nnc(C)c(N3CC(C)OC(C)C3)n2)cc1
2,6-dimethyl-4-[6-methyl-3-(4-methylphenyl)-1,2,4-triazin-5-yl]morpholine